top of page
Search
Hemp Pro For Life

CEO Spotlight: The BC Bud Co.

Apr 20, 2023



Today, we are lucky to have The BC Bud Co. CEO Brayden Sutton with us. During the last year, the company has reported impressive growth and we believe the business is in the middle of a major growth cycle. We are of the opinion that The BC Bud Co. is flying under the radar and hope this interview can help answer the questions that our readers have.

  1. Can you please tell our readers about The BC Bud Co. and the assets that are owned by the business?


    • The BC Bud Co is a house of brands aimed to deliver a standard of products to the recreational cannabis market that is consistent with the term BC BUD and the quality synonymous with the term. Currently, the assets owned by the business are the brands that continue to drive consumer awareness in a fragmented market. Brands continue to show their value as several companies recently have acquired groups brands, closing their facilities to utilize their SKU’s and relationships in provincial markets.


  1. During the last year, The BC Bud Co. has reported strong growth. What has been the most important growth drivers for the business?


    • The most important growth drivers to date have been brand health which continues to bring organic growth and increase brand awareness. We aim to match the quality we desire as consumers and operators with a price point that reciprocates the quality. We view this is an important factor given the instability and inconsistency of the legal market to date.


  1. When it comes to The BC Bud Co., the strength of the management team stands out as a key attribute. Can you tell us about the leadership team and its track record?


    • The leadership team comes with cannabis experience that dates back to medical cannabis legalization in Canada. Brayden Sutton has been part of several highly influential companies in North America including Supreme, Aurora, Origin House and 1933 Industries. Marc Lustig has been involved in countless cannabis companies including Cresco Labs, IMCannabis, Pharmacello, Planet 13. Mr. Lustig sold Origin House to Cresco Labs for $1.1 Billion in one of the premier cannabis sales to date worldwide.


  1. What are the most significant potential catalysts for The BC Bud Co?


    • The most significant catalysts for The BC Bud Co is the opportunity to acquire assets that compliment the company without taking on debt and high burn rates, something the company currently doesn’t have.


  1. Although Canada’s cannabis market has faced several challenges, The BC Bud Co. has continued to record strong growth. Can you tell us about the company’s growth strategy?


    • Continue to bring select products to market and expand distribution outside the 6 provinces we currently sell into. Look into licensing opportunities outside of Canada


  1. Over the next year, how do you see the business evolving and what should our readers be aware of?


    • Now that we have a sales team nationwide talking about the brand, we see our next year with increased retail presence, Quebec and Maritime entry, new genetics/cultivars to the market and increased direct delivery program for BC.


  1. How is The BC Bud Co. different from other Canadian cannabis operators?


    • The BC Bud Co is more than 72% owned by management, something very difficult to find within public companies. Operators that understand the products and vet them personally, with a unique team combining product expertise with significant capital markets experience.


If you are interested in learning more about The BC Bud Co., please send an email to support@technical420.com with the subject “The BC Bud Co” to be added to our distribution list.

Company Relationship Disclosure

T420 is responsible for the T420 opinions provided in this disclosure except all sources or information provided by other parties were not verified or authenticated and T420 does not undertake to confirm or substantiate or be responsible for such information provided by other parties.

Any Content posted regarding a Profiled Issuer is not a solicitation or recommendation to buy, sell or hold securities. We cannot and do not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. All information should be independently verified. We are not responsible for errors or omissions in our publications, and any opinions expressed are subject to change, without notice. We do not, nor are we under any obligation to undertake due diligence or investigation or authenticate and verify whatsoever regarding Profiled Issuers or any Content posted in relation thereto and we do not receive any verification from the Profiled Issuer regarding the Content we disseminate. Similarly, while we endeavor to facilitate the provision of quality information, we are not responsible for any loss or damages caused or alleged to have been caused by its use nor verify or authenticate or update such information.

Pursuant to an agreement between Spotlight Media Corp. and The BC Bud Co. we have been hired for a period of 180 days beginning February 15, 2023 and ending August 15, 2023 to publicly disseminate information about The BC Bud Co. including on the Website and other media including Facebook and Twitter. We are being paid $2,200 per month The BC Bud Co. and were paid “ZERO” shares common shares. We hold “ZERO” shares common shares. We will not sell or purchase shares during the Term. We reserve the right to buy or sell shares after the Term in accordance with State and Federal securities laws. See “Disclosures” below which is to be read in conjunction with this release.

This article contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs regarding future performance are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “expects”, “does not expect”, “is expected”, “believes”, “intends”, “anticipates”, “does not anticipate”, “believes” or variations of these words, expressions or statements, that certain actions, events or results “may”, “could”, “would”, “might” or “will be” taken, will occur or will be realized. Such forward-looking statements involve risks, uncertainties and other known and unknown factors that could cause actual results, events or developments to differ materially from the results, events or developments expected and expressed or implied in such forward-looking statements. These risks and uncertainties include, but are not limited to, dependence on obtaining and maintaining regulatory approvals, including the acquisition and renewal of federal, provincial, state, municipal, local or other licenses, and any inability to obtain all necessary government authorizations, licenses and permits to operate and expand the Company’s facilities; regulatory or policy changes such as changes in applicable laws and regulations, including federal, state and provincial legalization, due to fluctuations in public opinion, industry perception of integrative mental health, including the use of psychedelic-assisted therapy, delays or inefficiencies or any other reason; any other factor or development likely to hamper the growth of the market; the Company’s limited operating and profitability track record; dependence on management; the Company’s need for additional financing and the effects of financial market conditions and other factors on the availability of capital; competition, including that of more established and better funded competitors; the impact of the Russia-Ukraine conflict on the global economy; the continued impact of the COVID-19 pandemic; and the need to build and maintain alliances and partnerships, including with research and development companies, customers and suppliers. These factors should be carefully considered, and readers are cautioned not to place undue reliance on forward-looking statements. Despite the Company’s efforts to identify the main risk factors that could cause actual measures, events or results to differ materially from those described in forward-looking statements, other risk factors may cause measures, events or developments to materially differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company does not undertake to revise forward-looking statements, even if new information becomes available as a result of future events, new facts or any other reason, except as required by applicable laws



0 views

Comments


bottom of page